Recruiting
Phase 2

Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

Sponsor:

Academic and Community Cancer Research United

Code:

NCT04042831

Conditions

Bile Duct Adenocarcinoma

Fanconi Anemia Complementation Group Gene Mutation

Metastatic Bile Duct Carcinoma

PTEN Gene Deletion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Olaparib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information